Nabaparna Bhattacharya
Franklin Exponential Data ETF
XDAT · ETF
$26.91+$0.6532 (+2.49%)TodayMarket closed ·
Prev close $26.26
About XDAT
- Issuer
- Franklin
- Expense ratio
- 0.5%
- Assets under management
- $4.04M
- Inception
- Jan 12, 2021
- Asset class
- Equity
- Website
- franklintempleton.com
XDAT key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 974
- Volume
- 135
- Open price
- $26.26
- High today
- $26.91
- Low today
- $26.91
- 52 Week high
- $28.87
- 52 Week low
- $20.15
Franklin Exponential Data ETF (XDAT) at a glance
Franklin Exponential Data ETF (XDAT) last traded at $26.91, with a market cap of 0 and a price-to-earnings ratio of 0.00.
Volume so far is 135 shares, below the average of 974 shares a day.
Over the past year Franklin Exponential Data ETF has ranged from $20.15 to $28.87, and now sits 78% of the way up that range.
XDAT news
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.